Literature DB >> 9127971

Aging and Alzheimer's disease: lessons from the Nun Study.

D A Snowdon1.   

Abstract

Sister Mary, the gold standard for the Nun Study, was a remarkable woman who had high cognitive test scores before her death at 101 years of age. What is more remarkable is that she maintained this high status despite having abundant neurofibrillary tangles and senile plaques, the classic lesions of Alzheimer's disease. Findings from Sister Mary and all 678 participants in the Nun Study may provide unique clues about the etiology of aging and Alzheimer's disease, exemplify what is possible in old age, and show how the clinical expression of some diseases may be averted.

Entities:  

Mesh:

Year:  1997        PMID: 9127971     DOI: 10.1093/geront/37.2.150

Source DB:  PubMed          Journal:  Gerontologist        ISSN: 0016-9013


  57 in total

Review 1.  Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.

Authors:  Ernesto Solis; Kevin N Hascup; Erin R Hascup
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study.

Authors:  Karen S SantaCruz; Joshua A Sonnen; Maryam Kherad Pezhouh; Mark F Desrosiers; Peter T Nelson; Suzanne L Tyas
Journal:  J Neuropathol Exp Neurol       Date:  2011-10       Impact factor: 3.685

Review 3.  Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.

Authors:  Masashi Kitazawa; Rodrigo Medeiros; Frank M Laferla
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.

Authors:  Jirayu Tanprasertsuk; Elizabeth J Johnson; Mary Ann Johnson; Leonard W Poon; Peter T Nelson; Adam Davey; Peter Martin; Aron K Barbey; Kathryn Barger; Xiang-Dong Wang; Tammy M Scott
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

5.  Overview and findings from the religious orders study.

Authors:  David A Bennett; Julie A Schneider; Zoe Arvanitakis; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

6.  Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes.

Authors:  Diego Iacono; Susan M Resnick; Richard O'Brien; Alan B Zonderman; Yang An; Olga Pletnikova; Gay Rudow; Barbara Crain; Juan C Troncoso
Journal:  J Neuropathol Exp Neurol       Date:  2014-04       Impact factor: 3.685

Review 7.  Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?

Authors:  Jacques Fantini; Henri Chahinian; Nouara Yahi
Journal:  Protein Sci       Date:  2020-07-13       Impact factor: 6.725

8.  Longitudinal epidemiologic clinical-pathologic studies of aging and Alzheimer's disease.

Authors:  David A Bennett; Lenore J Launer
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

9.  NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease.

Authors:  Nicholas H Varvel; Kiran Bhaskar; Maria Z Kounnas; Steven L Wagner; Yan Yang; Bruce T Lamb; Karl Herrup
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

10.  Can lifestyle modification improve neurocognition? Rationale and design of the ENLIGHTEN clinical trial.

Authors:  James A Blumenthal; Patrick J Smith; Kathleen Welsh-Bohmer; Michael A Babyak; Jeffrey Browndyke; Pao-Hwa Lin; P Murali Doraiswamy; James Burke; William Kraus; Alan Hinderliter; Andrew Sherwood
Journal:  Contemp Clin Trials       Date:  2012-09-19       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.